Aarti Pharmalabs Limited

NSE AARTIPHARM.NS

Aarti Pharmalabs Limited Gross Profit Margin for the year ending March 31, 2024: 21.53%

Aarti Pharmalabs Limited Gross Profit Margin is 21.53% for the year ending March 31, 2024, a -46.00% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Aarti Pharmalabs Limited Gross Profit Margin for the year ending March 31, 2023 was 39.87%, a 147.41% change year over year.
  • Aarti Pharmalabs Limited Gross Profit Margin for the year ending March 31, 2022 was 16.11%.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
SV Wall Street
NSE: AARTIPHARM.NS

Aarti Pharmalabs Limited

CEO Ms. Hetal Gogri Gala
IPO Date Jan. 30, 2023
Location India
Headquarters Tower C, 401
Employees 2,095
Sector Healthcare
Industries
Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Fertilizers Personal Care Tobacco
Description

Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.

StockViz Staff

February 2, 2025

Any question? Send us an email